Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson's Disease. 2023

Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
Aix-Marseille Université, CNRS, LNC (UMR 729), 13331 Marseille, France.

Excessive inhibition of the external globus pallidus (GPe) by striatal GABAergic neurons is considered a central mechanism contributing to motor symptoms of Parkinson's disease (PD). While electrophysiological findings support this view, behavioral studies assessing the beneficial effects of global GPe activations are scarce and the reported results are controversial. We used an optogenetic approach and the standard unilateral 6-hydroxydopamine nigrostriatal dopamine (DA) lesion model of PD to explore the effects of GPe photostimulation on motor deficits in mice. Global optogenetic GPe inhibition was used in normal mice to verify whether it reproduced the typical motor impairment induced by DA lesions. GPe activation improved ipsilateral circling, contralateral forelimb akinesia, locomotor hypoactivity, and bradykinesia in 6-OHDA-lesioned mice at ineffective photostimulation parameters (532 nm, 5 Hz, 3 mW) in normal mice. GPe photoinhibition (450 nm, 12 mW) had no effect on locomotor activity and forelimb use in normal mice. Bilateral photoinhibition (450 nm, 6 mW/side) reduced directed exploration and improved working memory performances indicating that recruitment of GPe in physiological conditions may depend on the behavioral task involved. Collectively, these findings shed new light on the functional role of GPe and suggest that it is a promising target for neuromodulatory restoration of motor deficits in PD.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005917 Globus Pallidus The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus. Paleostriatum,Pallidum,Pallidums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D062308 Optogenetics The combination of genetic and optical methods in controlling specific events with temporal precision in targeted cells of a functioning intact biological system. Optogenetic Techniques,Optogenetic,Optogenetic Technique,Technique, Optogenetic,Techniques, Optogenetic
D018476 Hypokinesia Slow or diminished movement of body musculature. It may be associated with BASAL GANGLIA DISEASES; MENTAL DISORDERS; prolonged inactivity due to illness; and other conditions. Bradykinesia,Hypodynamia,Hypokinesia, Antiorthostatic,Antiorthostatic Hypokinesia,Antiorthostatic Hypokinesias,Bradykinesias,Hypokinesias, Antiorthostatic

Related Publications

Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
May 2013, Neurotoxicology,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
January 2009, Neuro-Signals,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
March 2007, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
October 2007, Movement disorders : official journal of the Movement Disorder Society,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
January 1995, British journal of neurosurgery,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
May 2010, Journal of neuroscience research,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
March 2020, Journal of neuroscience research,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
December 2015, Journal of neural transmission (Vienna, Austria : 1996),
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
July 2002, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Sonia Di Bisceglie Caballero, and Aurelia Ces, and Martine Liberge, and Frederic Ambroggi, and Marianne Amalric, and Abdel-Mouttalib Ouagazzal
December 2015, Movement disorders clinical practice,
Copied contents to your clipboard!